Susanna Gatti High, Chief Operating Officer at Dyne Therapeutics, Inc. (DYN), sold 58,691 shares at $26.66 ($1.6M) on 2024-03-08, disclosed to the SEC on 2024-03-13.
Scheduled sale ($1.6M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.66 | 26,908 | $717K | 46.0% |
| 2 | $26.66 | 26,908 | $717K | 46.0% |
| 3 | $27.41 | 291 | $8K | 0.5% |
| 4 | $25.70 | 2,292 | $59K | 3.8% |
| 5 | $25.70 | 2,292 | $59K | 3.8% |
| Total | $26.59 avg | 58,691 |
| $1.6M |
| 100% |
| Filing → |
| DYN | SELL | 2024-08-20 | $248K | — | Filing → |
| DYN | SELL | 2024-07-03 | $722K | — | Filing → |
| DYN | SELL | 2024-06-24 | $2.4M | — | Filing → |